Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 21, 2005

View Archived Issues

Neuroprotective effects of beta-lactam antibiotics

BMP-7 effective in preclinical models of Parkinson's disease and kidney injury

Teduglutide is a potential anti-mucositis therapeutic for chemotherapy patients

Parthenolide: a novel agent from a natural product with potent antileishmanial activity in vitro

GlobeImmune and MycoLogics enter agreement for antifungal vaccines

Phase II trial investigates alagebrium chloride for erectile dysfunction

DPP-IV inhibitor PSN-9301 enters phase II study

Phase II study evaluates recombinant microplasmin in vitreoretinal disorders

Positive preliminary phase III results for Sativex in severe cancer pain

Addex and Ortho-McNeil collaborate in anxiety, depression, schizophrenia

AN-152 enters clinical development

NIAID begins second phase I study of HIV vaccine

Not approvable letter for Marqibo

ID Biomedical commences development of vaccine against H5N1 influenza strain

Advanced Biotherapy completes pilot study in genital herpes

Adenosine Therapeutics enters collaboration agreement in asthma and diabetes

Vesicare available in U.S.

Roche patent covers adenosine A2A receptor ligands

Fujisawa and Wakunaga jointly report novel cephem antibiotics

Pfizer researchers describe androgen receptor antagonists

Protein tyrosine phosphatase PTP-1B inhibitors under study at Roche

MMP inhibitors for treatment of inflammatory conditions

Update on the antitumor effects of bortezomib in MM and non-Hodgkin's lymphoma

BMAP-28 reported to reduce lethality associated with staphylococcal sepsis in mice

OM-197-MP-AC induces maturation of dendritic cells in vitro

IRAK1 shows promise as a novel target in the treatment of atherosclerosis

R-130823, a p38 MAPK inhibitor, effective in models of rheumatoid arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...